肺部抗体可在呼出气体中检测
Lung antibodies can be measured in exhaled breath
研究人员首次成功在呼出气体中检测到针对特定呼吸道病毒的抗体,使用非侵入性方法PExA收集并分析了来自小气道黏膜的微小颗粒。该方法有助于研究肺部不同区域的免疫反应差异,未来可用于评估呼吸道感染或疫苗后的免疫变化。
For the first time, researchers have successfully measured antibodies against specific respiratory viruses in exhaled air. The new study, involving the Karolinska Institutet, was published in eBioMedicine. The method may make it easier to study the immune system in the small airways of the lungs.
Antibodies in the mucosal lining of the respiratory tract play an important role in protecting against respiratory viruses such as the influenza virus, SARS-CoV-2 and respiratory syncytial virus (RSV). While antibodies in the upper airways are relatively easy to measure, sampling from the lower airways has previously required invasive procedures such as bronchoscopy.
In the new study, researchers used a noninvasive method called PExA (Particles in Exhaled Air). By breathing into a specially designed instrument, participants generated tiny exhaled particles originating from the respiratory tract lining fluid of the small airways. These particles were collected and analyzed for virus-specific antibodies.
"Antibodies in the nasal mucosa are important for protection against respiratory infections, but immune responses further down the lungs are also crucial, particularly for preventing severe disease such as pneumonia. This method opens up new possibilities for understanding how immunity differs between the upper and lower airways," says Charlotte Thålin, adjunct professor at the Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, and co-last author of the study.
The study included 28 participants in the COMMUNITY cohort at Danderyd Hospital, 18 of whom had recently experienced a respiratory tract infection. The researchers analyzed paired samples from blood, nasal secretions and exhaled breath.
In the exhaled breath samples, the researchers successfully detected IgA and IgG antibodies directed against SARS-CoV-2, influenza virus and RSV. Virus-specific IgG levels in the lower airway samples largely mirrored those observed in blood, whereas IgA showed a different pattern, consistent with a greater contribution from local mucosal antibody responses.
In the future, the method could help researchers investigate how immune responses in the lower airways change following respiratory infections or vaccinations and support the evaluation of preventive treatments. The researchers emphasize that this was an initial methodological study involving a limited number of participants and that further validation in larger studies is needed.
Publication details
Katherina Aguilera et al., Non-invasive quantification of lower airway antigen-specific antibodies using exhaled breath particles – an observational proof-of-concept study, eBioMedicine (2026). DOI: 10.1016/j.ebiom.2026.106538
Journal information: EBioMedicine
Key medical concepts
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Lung antibodies can be measured in exhaled breath (2026, November 4) retrieved 4 November 2026 from https://medicalxpress.com/news/2026-11-lung-antibodies-exhaled.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com